Ondansetron Use for Preventing Pruritus In Patients Undergoing Cesarean Section
Condition(s):Pruritus Caused by DrugLast Updated:March 12, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Pruritus Caused by DrugLast Updated:March 12, 2024Not yet recruiting
Condition(s):Malignant Childhood NeoplasmLast Updated:October 8, 2013Withdrawn
Condition(s):Vasovagal Syncope (VVS); SyncopeLast Updated:May 11, 2023Not yet recruiting
Condition(s):Percutaneous NephrolithotomyLast Updated:September 26, 2022Completed
Condition(s):Postoperative PainLast Updated:March 13, 2015Completed
Condition(s):Adverse Anesthesia OutcomeLast Updated:August 31, 2016Unknown status
Condition(s):Hyperemesis Gravidarum; Nausea Gravidarum; Vomiting of PregnancyLast Updated:January 30, 2023Terminated
Condition(s):Ondansetron; Cesarean Section; Spinal Anesthesia; HemodynamicsLast Updated:August 14, 2018Completed
Condition(s):Cardiac OutputLast Updated:May 11, 2018Completed
Condition(s):Motility Disorder of Intestine; Ondansetron; Small Bowel WaterLast Updated:November 27, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.